Find your next paid study

National Institutes of Health Clinical Center (CC)NCT00001846

~$10 – $675

Mohs Micrographic SurgeryCutaneous MalignancyMohs Surgical Defect

A Multicenter, Prospective, Randomized Controlled Clinical Trial Assessing the Efficacy of a Novel Cellular, Acellular, Matrix-like Product (CAMP) Plus Standard of Care Versus Standard of Care Alone in the Management of Post-Mohs Micrographic Surgery Defects.

A multicenter, prospective, randomized controlled clinical trial assessing the efficacy of a novel cellular, acellular, matrix-like product (CAMP) plus standar…

BioLab HoldingsNCT07695389

~$10 – $7,500

Phase 1

Phase 1/2, Open-Label, Multicenter, Dose Escalation and Expansion Study of BHB810 in Participants With Advanced Gastric and Gastroesophageal Junction Adenocarcinoma

This study is looking at how safe BHB810 is in adults with gastric and gastroesophageal adenocarcinoma (GEJ). The purpose of this study is also to look at: how…

Gastric CancerGastric AdenocarcinomaGastric (Stomach) Cancer+11 more

BigHat Biosciences, Inc.NCT07529808

~$10 – $8,750

Cystic FibrosisSickle Cell DiseaseSARS CoV 2 Infection

Revamping Exercise Assessments in Child Health (Project REACH)

This study is a cooperative investigation funded by the NIH. The project is a collaboration among three major NIH Clinical Translational Science Awardees: 1) U…

University of California, IrvineNCT05359991

Colorectal NeoplasmsMass Screening

Preventing Early-Onset Colorectal Cancer in the VA Using a Multilevel Screening Intervention

Colorectal cancer is a leading cause of cancer death among Veterans. The starting age for colorectal cancer screening has been lowered from 50 to 45 years in r…

VA Office of Research and DevelopmentNCT07071454

~$10 – $5,625

Florida Community-Engaged Research Alliance (FL-CEAL)

The purpose of the study is learn more about ways to help people with non-medical issues that can affect participant health. The study team will examine if Com…

Health, Subjective

University of MiamiNCT06829485

Patient-Centered Surgical Prehabilitation

The purpose of this research is to validate the prehabilitation program which is defined as a set of interventions meant to prepare the body physically and nut…

Bladder CancerCystectomy

Brigham and Women's HospitalNCT05715684

Phase 2

A Single-Arm Phase II Clinical Trial of Gemcitabine, Cisplatin, and Nab-Paclitaxel as Neoadjuvant Therapy for Pancreatic Ductal Adenocarcinoma

This phase II trial tests how well gemcitabine, cisplatin and nab-paclitaxel given before surgery (neoadjuvant) works in treating patients with pancreatic canc…

Borderline Resectable Pancreatic Ductal AdenocarcinomaResectable Pancreatic AdenocarcinomaStage I Pancreatic Cancer AJCC v8+2 more

Georgetown UniversityNCT06423326

Host Response to Infection and Treatment in the Filarial Diseases of Humans

This study will evaluate and treat patients with filarial infections to explore in depth the immunology of the disease, including susceptibility to infection, …

FilariasisHelminthiasisParasitic Infection+2 more

National Institute of Allergy and Infectious Diseases (NIAID)NCT00001230

~$10 – $675

Phase 3

A Randomized, Multi-Center, Parallel, Double-Blinded, Placebo-Controlled Clinical Trial to Evaluate Efficacy, Safety, and Pharmacokinetics of XEMBIFY® Plus Standard Medical Treatment Compared to Placebo Plus Standard Medical Treatment to Prevent Infections in Patients With Hypogammaglobulinemia and Recurrent or Severe Infections Associated With B-cell Chronic Lymphocytic Leukemia, Multiple Myeloma, and Non-Hodgkin Lymphoma

The primary purpose of the study is to evaluate whether biweekly administered XEMBIFY® plus Standard Medical Treatment (SMT) over a one-year period will reduce…

HypogammaglobulinemiaBacterial InfectionsB-cell Chronic Lymphocytic Leukemia+2 more

Grifols Therapeutics LLCNCT05645107

~$10 – $8,750

Natural History, Genetics, Phenotype, and Treatment of Mycobacterial Infections

This study will examine the symptoms, course of disease and treatment of non-tuberculous mycobacterial (NTM) infections, as well as the genetics involved in th…

Mycobacterium Infections

National Institute of Allergy and Infectious Diseases (NIAID)NCT00018044

~$10 – $675

Phase 2

A Phase IIb Randomized, Double-blind, Placebo-controlled, Parallel, Multidose Study to Evaluate the Efficacy, Safety, and PK of AZD0292 in Participants 12 Years of Age and Older With Bronchiectasis and Chronic Pseudomonas Aeruginosa Colonization

AZD0292 is a bispecific IgG1k mAb being evaluated for the prevention of exacerbations in bronchiectasis patients chronically colonized with PsA.

Bronchiectasis With Pseudomonas Aeruginosa Colonization